Paradigm Biocapital Advisors LP
Filing Date
Global Rank
#676
/ 8,603
▲ 173
· as of Mar 2026
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+4.5%
Period ended 3 months ago
Filed May 15, 2026 · 55d
18 quarters · since Dec 2021
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+97.9%
SPY
+76.0%
Annualised alpha
+4.8%
Max drawdown
−47.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
35 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
13.5%
−1.3 pts
Top 5
48.3%
−3.8 pts
Top 10
67.6%
−8.7 pts
HHI
671
Diversified−112
Portfolio Trend
18 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $4,894,261,596 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
13 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\DE | +1,705,791 | 3,148,893 | $61,592,347 | |
| LXEO | Lexeo Therapeutics, Inc. | +1,420,936 | 6,184,134 | $35,496,929 | |
| TERN | Terns Pharmaceuticals, Inc. | +1,406,213 | 2,216,499 | $116,853,827 | |
| GMAB | Genmab A/S | +928,002 | 7,967,836 | $213,777,039 | |
| EWTX | Edgewise Therapeutics, Inc. | +823,828 | 7,365,038 | $231,998,697 | |
| PCVX | Vaxcyte, Inc. | +725,000 | 4,793,020 | $278,522,392 | |
| ORKA | Oruka Therapeutics, Inc. | +610,000 | 2,320,316 | $113,811,499 | |
| SYRE | Spyre Therapeutics, Inc. | +490,000 | 1,957,266 | $98,724,497 | |
| OLMA | Olema Pharmaceuticals, Inc. | +476,404 | 8,020,576 | $119,586,788 | |
| APGE | Apogee Therapeutics, Inc. | +225,000 | 1,348,243 | $113,481,613 | |
| NUVL | Nuvalent, Inc. | +55,000 | 5,324,433 | $545,488,160 | |
| ACLX | Arcellx, Inc. | +50,000 | 5,774,016 | $662,972,517 | |
| RVMD | Revolution Medicines, Inc. | +11,300 | 6,655,703 | $647,267,116 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
7 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ERAS | Erasca, Inc. | −3,766,393 | 10,392,702 | $168,153,918 | |
| URGN | UroGen Pharma Ltd. | −2,769,699 | 1,703,949 | $30,637,003 | |
| SRRK | Scholar Rock Holding Corp | −1,836,077 | 1,226,080 | $60,274,092 | |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | −1,393,536 | 868,213 | $7,770,506 | |
| ORIC | Oric Pharmaceuticals, Inc. | −700,000 | 1,701,217 | $21,554,419 | |
| ABVX | Abivax S.A. | −645,000 | 772,473 | $86,014,868 | |
| EYPT | EyePoint, Inc. | −549,038 | 3,142,437 | $40,506,012 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
10 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| INSM | INSMED Inc | 1,254,488 | $205,133,877 | |
| BLTE | Belite Bio, Inc | 1,114,784 | $177,741,160 | |
| CNTA | Centessa Pharmaceuticals plc | 3,574,048 | $141,961,186 | |
| CYTK | Cytokinetics Inc | 1,480,857 | $97,603,284 | |
| TNGX | Tango Therapeutics, Inc. | 4,009,679 | $83,882,484 | |
| MAZE | Maze Therapeutics, Inc. | 2,744,399 | $81,920,310 | |
| TYRA | Tyra Biosciences, Inc. | 2,054,991 | $78,706,155 | |
| MIRM | Mirum Pharmaceuticals, Inc. | 625,000 | $57,737,500 | |
| MANE | Veradermics, Inc | 525,000 | $33,153,750 | |
| GPCR | Structure Therapeutics Inc. | 545,287 | $26,282,833 | |
| No positions match the current search. | ||||
35 positions ·
$4,894,261,596 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ACLX |
Arcellx, Inc.
Healthcare
|
Added | 5,774,016 | $662,972,517 | 13.55% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 6,655,703 | $647,267,116 | 13.23% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Added | 5,324,433 | $545,488,160 | 11.15% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 4,793,020 | $278,522,392 | 5.69% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 7,365,038 | $231,998,697 | 4.74% | |
| GMAB |
Genmab A/S
Healthcare
|
Added | 7,967,836 | $213,777,039 | 4.37% | |
| INSM |
INSMED Inc
Healthcare
|
NEW | 1,254,488 | $205,133,877 | 4.19% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Held | 2,562,154 | $179,735,103 | 3.67% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
NEW | 1,114,784 | $177,741,160 | 3.63% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Reduced | 10,392,702 | $168,153,918 | 3.44% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
NEW | 3,574,048 | $141,961,186 | 2.90% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Added | 8,020,576 | $119,586,788 | 2.44% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Added | 2,216,499 | $116,853,827 | 2.39% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Added | 2,320,316 | $113,811,499 | 2.33% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Added | 1,348,243 | $113,481,613 | 2.32% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Added | 1,957,266 | $98,724,497 | 2.02% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 1,480,857 | $97,603,284 | 1.99% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 772,473 | $86,014,868 | 1.76% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
NEW | 4,009,679 | $83,882,484 | 1.71% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
NEW | 2,744,399 | $81,920,310 | 1.67% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
NEW | 2,054,991 | $78,706,155 | 1.61% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Added | 3,148,893 | $61,592,347 | 1.26% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Reduced | 1,226,080 | $60,274,092 | 1.23% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
NEW | 625,000 | $57,737,500 | 1.18% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Reduced | 3,142,437 | $40,506,012 | 0.83% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Added | 6,184,134 | $35,496,929 | 0.73% | |
| MANE |
Veradermics, Inc
Healthcare
|
NEW | 525,000 | $33,153,750 | 0.68% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
Held | 1,750,000 | $31,220,000 | 0.64% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Reduced | 1,703,949 | $30,637,003 | 0.63% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
NEW | 545,287 | $26,282,833 | 0.54% | |
| IVA |
Inventiva S.A.
Healthcare
|
Held | 4,000,000 | $22,200,000 | 0.45% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,701,217 | $21,554,419 | 0.44% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Held | 665,251 | $18,460,715 | 0.38% | |
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
Reduced | 868,213 | $7,770,506 | 0.16% | |
| KLRS |
Kalaris Therapeutics, Inc.
Healthcare
|
Held | 700,000 | $4,039,000 | 0.08% |